Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

Autoantibodies present at onset of type I diabetes recognize multiple islet cell antigens.

Karounos DG, Nell LJ, Thomas JW.

Autoimmunity. 1990;6(1-2):79-91.

PMID:
2129772
2.

Type I diabetes mellitus: a predictable autoimmune disease with interindividual variation in the rate of beta cell destruction.

Dotta F, Eisenbarth GS.

Clin Immunol Immunopathol. 1989 Jan;50(1 Pt 2):S85-95. Review.

PMID:
2642771
3.

Cytoplasmic islet cell antibodies recognize distinct islet antigens in IDDM but not in stiff man syndrome.

Richter W, Seissler J, Northemann W, Wolfahrt S, Meinck HM, Scherbaum WA.

Diabetes. 1993 Nov;42(11):1642-8.

PMID:
8405707
4.

Contribution of glutamate decarboxylase antibodies to the reactivity of islet cell cytoplasmic antibodies.

Marshall MO, Høyer PE, Petersen JS, Hejnaes KR, Genovese S, Dyrberg T, Bottazzo GF.

J Autoimmun. 1994 Aug;7(4):497-508.

PMID:
7980851
5.
6.

Recognition of common islet antigen by autoantibodies from NOD mice and humans with IDDM.

Karounos DG, Thomas JW.

Diabetes. 1990 Sep;39(9):1085-90.

PMID:
2200729
7.

Autoantibodies to a 38-kDa glycosylated islet cell membrane-associated antigen in (pre)type 1 diabetes: association with IA-2 and islet cell autoantibodies.

Winnock F, Christie MR, Batstra MR, Aanstoot HJ, Weets I, Decochez K, Jopart P, Nicolaij D, Gorus FK; Belgian Diabetes Registry.

Diabetes Care. 2001 Jul;24(7):1181-6.

PMID:
11423499
8.

The 37/40-kilodalton autoantigen in insulin-dependent diabetes mellitus is the putative tyrosine phosphatase IA-2.

Passini N, Larigan JD, Genovese S, Appella E, Sinigaglia F, Rogge L.

Proc Natl Acad Sci U S A. 1995 Sep 26;92(20):9412-6.

9.

Distinct antibody specificities to a 64-kD islet cell antigen in type 1 diabetes as revealed by trypsin treatment.

Christie MR, Vohra G, Champagne P, Daneman D, Delovitch TL.

J Exp Med. 1990 Sep 1;172(3):789-94.

11.

Islet glutamic acid decarboxylase modified by reactive oxygen species is recognized by antibodies from patients with type 1 diabetes mellitus.

Trigwell SM, Radford PM, Page SR, Loweth AC, James RF, Morgan NG, Todd I.

Clin Exp Immunol. 2001 Nov;126(2):242-9.

14.

The heterogeneity of whole islet cell cytoplasmic antibodies evidenced by absorption test with glutamic acid decarboxylase.

Takino H, Kawasaki E, Yano M, Matsumoto K, Uotani S, Okuno S, Takao Y, Yamasaki H, Yamaguchi Y, Akazawa S, et al.

J Autoimmun. 1994 Jun;7(3):389-98.

PMID:
7916910
15.

[Detection of antibodies against pancreatic islet cells in clinical practice].

Pánczél P, Külkey O, Luczay A, Bornemisza B, Illyés G, Halmos T, Baranyi E, Blatniczky L, Mészáros J, Kerényi Z, Geró L, Tamás G, Hosszúfalusi N, Horváth L, Madácsy L, Romics L.

Orv Hetil. 1999 Nov 28;140(48):2695-701. Hungarian.

PMID:
10645715
16.

Antibodies to a 64,000 Mr human islet cell antigen precede the clinical onset of insulin-dependent diabetes.

Baekkeskov S, Landin M, Kristensen JK, Srikanta S, Bruining GJ, Mandrup-Poulsen T, de Beaufort C, Soeldner JS, Eisenbarth G, Lindgren F, et al.

J Clin Invest. 1987 Mar;79(3):926-34.

17.

Identification and characterization of glima 38, a glycosylated islet cell membrane antigen, which together with GAD65 and IA2 marks the early phases of autoimmune response in type 1 diabetes.

Aanstoot HJ, Kang SM, Kim J, Lindsay LA, Roll U, Knip M, Atkinson M, Mose-Larsen P, Fey S, Ludvigsson J, Landin L, Bruining J, Maclaren N, Akerblom HK, Baekkeskov S.

J Clin Invest. 1996 Jun 15;97(12):2772-83.

18.

Gangliosides and autoimmune diabetes.

Misasi R, Dionisi S, Farilla L, Carabba B, Lenti L, Di Mario U, Dotta F.

Diabetes Metab Rev. 1997 Sep;13(3):163-79. Review.

PMID:
9307889
19.
20.

64,000-Mr autoantigen in type I diabetes. Evidence against its surface location on human islets.

Colman PG, Campbell IL, Kay TW, Harrison LC.

Diabetes. 1987 Dec;36(12):1432-40.

PMID:
3315789

Supplemental Content

Support Center